Silicone breast implants: The role of immune system on capsular contracture formation

D. Granchi, D. Cavedagna, G. Ciapetti, S. Stea, P. Schiavon, R. Giuliani, A. Pizzoferrato

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

We evaluated the role of the immune system in the pathogenesis of the periprosthetic capsular contracture, the most frequently occurring complication following the implant of silicone prosthesis. Peripheral blood samples from 22 patients with silicone-gel-filled implants were examined. In all cases a capsule was felt by palpation, and it was classified according to the Baker scale. Ten patients (group 1) had a Baker 2 contracture, and 12 (group 2) had severe contracture rated 3 and 4. The cells positive to antigens CD3, CD4, CD8, HLA-DR, CD19, CD25, CD57, CD16, and CD14, and the cytotoxic activity of the lymphocytes on target cells K562 were assessed by cytofluorimetric analysis. At time 0 there were no statistically significant differences between patients and normal subjects, nor between the two groups. At 48 h, the group 2 patients had a number/mm 3 of cells CD57 + significantly higher than both group 1 and control group (P <.05). In group 1 patients, the cytotoxic activity was similar to that of normal subjects, whereas in group 2 it was significantly increased, in respect to both the controls (P <.05) and group 1 (P <.001). In all groups, the contact of the lymphocytes with the silicone extract did not modify either the antigen expression or the lymphocyte functional activity. On the basis of these results we hypothesize the involvement of the immune system in the formation of the capsular contracture around the prosthesis.

Original languageEnglish
Pages (from-to)197-202
Number of pages6
JournalJournal of Biomedical Materials Research
Volume29
Issue number2
DOIs
Publication statusPublished - Feb 1995

Fingerprint

Breast Implants
Lymphocytes
Immune system
Contracture
Silicones
Immune System
Antigens
Silicone Gels
CD3 Antigens
Prostheses and Implants
HLA-DR Antigens
Capsules
Blood
Gels
CD4 Antigens
K562 Cells
Palpation
Control Groups

ASJC Scopus subject areas

  • Biomedical Engineering
  • Biomaterials

Cite this

Silicone breast implants : The role of immune system on capsular contracture formation. / Granchi, D.; Cavedagna, D.; Ciapetti, G.; Stea, S.; Schiavon, P.; Giuliani, R.; Pizzoferrato, A.

In: Journal of Biomedical Materials Research, Vol. 29, No. 2, 02.1995, p. 197-202.

Research output: Contribution to journalArticle

Granchi, D. ; Cavedagna, D. ; Ciapetti, G. ; Stea, S. ; Schiavon, P. ; Giuliani, R. ; Pizzoferrato, A. / Silicone breast implants : The role of immune system on capsular contracture formation. In: Journal of Biomedical Materials Research. 1995 ; Vol. 29, No. 2. pp. 197-202.
@article{e16f46af04244c0a8bafd8da6fefda0b,
title = "Silicone breast implants: The role of immune system on capsular contracture formation",
abstract = "We evaluated the role of the immune system in the pathogenesis of the periprosthetic capsular contracture, the most frequently occurring complication following the implant of silicone prosthesis. Peripheral blood samples from 22 patients with silicone-gel-filled implants were examined. In all cases a capsule was felt by palpation, and it was classified according to the Baker scale. Ten patients (group 1) had a Baker 2 contracture, and 12 (group 2) had severe contracture rated 3 and 4. The cells positive to antigens CD3, CD4, CD8, HLA-DR, CD19, CD25, CD57, CD16, and CD14, and the cytotoxic activity of the lymphocytes on target cells K562 were assessed by cytofluorimetric analysis. At time 0 there were no statistically significant differences between patients and normal subjects, nor between the two groups. At 48 h, the group 2 patients had a number/mm 3 of cells CD57 + significantly higher than both group 1 and control group (P <.05). In group 1 patients, the cytotoxic activity was similar to that of normal subjects, whereas in group 2 it was significantly increased, in respect to both the controls (P <.05) and group 1 (P <.001). In all groups, the contact of the lymphocytes with the silicone extract did not modify either the antigen expression or the lymphocyte functional activity. On the basis of these results we hypothesize the involvement of the immune system in the formation of the capsular contracture around the prosthesis.",
author = "D. Granchi and D. Cavedagna and G. Ciapetti and S. Stea and P. Schiavon and R. Giuliani and A. Pizzoferrato",
year = "1995",
month = "2",
doi = "10.1002/jbm.820290209",
language = "English",
volume = "29",
pages = "197--202",
journal = "Journal of Biomedical Materials Research - Part A",
issn = "1549-3296",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Silicone breast implants

T2 - The role of immune system on capsular contracture formation

AU - Granchi, D.

AU - Cavedagna, D.

AU - Ciapetti, G.

AU - Stea, S.

AU - Schiavon, P.

AU - Giuliani, R.

AU - Pizzoferrato, A.

PY - 1995/2

Y1 - 1995/2

N2 - We evaluated the role of the immune system in the pathogenesis of the periprosthetic capsular contracture, the most frequently occurring complication following the implant of silicone prosthesis. Peripheral blood samples from 22 patients with silicone-gel-filled implants were examined. In all cases a capsule was felt by palpation, and it was classified according to the Baker scale. Ten patients (group 1) had a Baker 2 contracture, and 12 (group 2) had severe contracture rated 3 and 4. The cells positive to antigens CD3, CD4, CD8, HLA-DR, CD19, CD25, CD57, CD16, and CD14, and the cytotoxic activity of the lymphocytes on target cells K562 were assessed by cytofluorimetric analysis. At time 0 there were no statistically significant differences between patients and normal subjects, nor between the two groups. At 48 h, the group 2 patients had a number/mm 3 of cells CD57 + significantly higher than both group 1 and control group (P <.05). In group 1 patients, the cytotoxic activity was similar to that of normal subjects, whereas in group 2 it was significantly increased, in respect to both the controls (P <.05) and group 1 (P <.001). In all groups, the contact of the lymphocytes with the silicone extract did not modify either the antigen expression or the lymphocyte functional activity. On the basis of these results we hypothesize the involvement of the immune system in the formation of the capsular contracture around the prosthesis.

AB - We evaluated the role of the immune system in the pathogenesis of the periprosthetic capsular contracture, the most frequently occurring complication following the implant of silicone prosthesis. Peripheral blood samples from 22 patients with silicone-gel-filled implants were examined. In all cases a capsule was felt by palpation, and it was classified according to the Baker scale. Ten patients (group 1) had a Baker 2 contracture, and 12 (group 2) had severe contracture rated 3 and 4. The cells positive to antigens CD3, CD4, CD8, HLA-DR, CD19, CD25, CD57, CD16, and CD14, and the cytotoxic activity of the lymphocytes on target cells K562 were assessed by cytofluorimetric analysis. At time 0 there were no statistically significant differences between patients and normal subjects, nor between the two groups. At 48 h, the group 2 patients had a number/mm 3 of cells CD57 + significantly higher than both group 1 and control group (P <.05). In group 1 patients, the cytotoxic activity was similar to that of normal subjects, whereas in group 2 it was significantly increased, in respect to both the controls (P <.05) and group 1 (P <.001). In all groups, the contact of the lymphocytes with the silicone extract did not modify either the antigen expression or the lymphocyte functional activity. On the basis of these results we hypothesize the involvement of the immune system in the formation of the capsular contracture around the prosthesis.

UR - http://www.scopus.com/inward/record.url?scp=0029239614&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029239614&partnerID=8YFLogxK

U2 - 10.1002/jbm.820290209

DO - 10.1002/jbm.820290209

M3 - Article

C2 - 7738066

AN - SCOPUS:0029239614

VL - 29

SP - 197

EP - 202

JO - Journal of Biomedical Materials Research - Part A

JF - Journal of Biomedical Materials Research - Part A

SN - 1549-3296

IS - 2

ER -